S&P 500   4,687.03 (+2.08%)
DOW   35,737.28 (+1.45%)
QQQ   397.74 (+2.99%)
AAPL   170.91 (+3.38%)
MSFT   334.97 (+2.69%)
FB   324.03 (+1.94%)
GOOGL   2,938.41 (+2.63%)
AMZN   3,538.01 (+3.23%)
TSLA   1,042.74 (+3.34%)
NVDA   320.40 (+6.67%)
BABA   125.28 (+1.36%)
NIO   33.17 (+2.57%)
CGC   10.81 (+6.50%)
AMD   145.24 (+4.44%)
GE   97.82 (+1.89%)
MU   86.66 (+5.11%)
T   23.10 (-0.77%)
F   19.82 (+3.12%)
DIS   150.11 (-0.17%)
PFE   51.40 (-0.16%)
AMC   30.96 (+7.54%)
ACB   6.39 (+7.04%)
BA   209.96 (+1.98%)
S&P 500   4,687.03 (+2.08%)
DOW   35,737.28 (+1.45%)
QQQ   397.74 (+2.99%)
AAPL   170.91 (+3.38%)
MSFT   334.97 (+2.69%)
FB   324.03 (+1.94%)
GOOGL   2,938.41 (+2.63%)
AMZN   3,538.01 (+3.23%)
TSLA   1,042.74 (+3.34%)
NVDA   320.40 (+6.67%)
BABA   125.28 (+1.36%)
NIO   33.17 (+2.57%)
CGC   10.81 (+6.50%)
AMD   145.24 (+4.44%)
GE   97.82 (+1.89%)
MU   86.66 (+5.11%)
T   23.10 (-0.77%)
F   19.82 (+3.12%)
DIS   150.11 (-0.17%)
PFE   51.40 (-0.16%)
AMC   30.96 (+7.54%)
ACB   6.39 (+7.04%)
BA   209.96 (+1.98%)
S&P 500   4,687.03 (+2.08%)
DOW   35,737.28 (+1.45%)
QQQ   397.74 (+2.99%)
AAPL   170.91 (+3.38%)
MSFT   334.97 (+2.69%)
FB   324.03 (+1.94%)
GOOGL   2,938.41 (+2.63%)
AMZN   3,538.01 (+3.23%)
TSLA   1,042.74 (+3.34%)
NVDA   320.40 (+6.67%)
BABA   125.28 (+1.36%)
NIO   33.17 (+2.57%)
CGC   10.81 (+6.50%)
AMD   145.24 (+4.44%)
GE   97.82 (+1.89%)
MU   86.66 (+5.11%)
T   23.10 (-0.77%)
F   19.82 (+3.12%)
DIS   150.11 (-0.17%)
PFE   51.40 (-0.16%)
AMC   30.96 (+7.54%)
ACB   6.39 (+7.04%)
BA   209.96 (+1.98%)
S&P 500   4,687.03 (+2.08%)
DOW   35,737.28 (+1.45%)
QQQ   397.74 (+2.99%)
AAPL   170.91 (+3.38%)
MSFT   334.97 (+2.69%)
FB   324.03 (+1.94%)
GOOGL   2,938.41 (+2.63%)
AMZN   3,538.01 (+3.23%)
TSLA   1,042.74 (+3.34%)
NVDA   320.40 (+6.67%)
BABA   125.28 (+1.36%)
NIO   33.17 (+2.57%)
CGC   10.81 (+6.50%)
AMD   145.24 (+4.44%)
GE   97.82 (+1.89%)
MU   86.66 (+5.11%)
T   23.10 (-0.77%)
F   19.82 (+3.12%)
DIS   150.11 (-0.17%)
PFE   51.40 (-0.16%)
AMC   30.96 (+7.54%)
ACB   6.39 (+7.04%)
BA   209.96 (+1.98%)
OTCMKTS:UCLE

US Nuclear Stock Forecast, Price & News

$0.26
-0.04 (-13.32%)
(As of 12/6/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.25
$0.29
50-Day Range
$0.26
$0.48
52-Week Range
$0.15
$1.38
Volume
103,815 shs
Average Volume
78,110 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive UCLE News and Ratings via Email

Sign-up to receive the latest news and ratings for US Nuclear and its competitors with MarketBeat's FREE daily newsletter.


US Nuclear logo

About US Nuclear

US Nuclear Corp. engages in the design, building, and manufacture of radiation safety and monitoring instruments. It operates through the Optron, Overhoff, and Corporate segments. The Optron segment is located in Canoga Park, California. The Overhoff segment is located in located in Milford, Ohio. The company was founded on February 14, 2012 and is headquartered in Canoga Park, CA.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Scientific & Technical Instruments
Sub-Industry
N/A
Current Symbol
OTCMKTS:UCLE
Previous Symbol
NASDAQ:UCLE
Fax
N/A
Employees
6
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

0.93 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












US Nuclear (OTCMKTS:UCLE) Frequently Asked Questions

How has US Nuclear's stock price been impacted by COVID-19?

US Nuclear's stock was trading at $0.77 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, UCLE stock has decreased by 66.2% and is now trading at $0.2603.
View which stocks have been most impacted by COVID-19
.

Who are US Nuclear's key executives?

US Nuclear's management team includes the following people:
  • Robert I. Goldstein, Chairman, President & Chief Executive Officer
  • Richard Landry, COO & Director-Investor Relations
  • Rachel Boulds, Chief Financial Officer & Secretary

What other stocks do shareholders of US Nuclear own?

Based on aggregate information from My MarketBeat watchlists, some companies that other US Nuclear investors own include IntelGenx Technologies (IGXT), Acasti Pharma (ACST), Aethlon Medical (AEMD), General Cannabis (CANN), (HSDT), KemPharm (KMPH), Naked Brand Group (NAKD), Ocugen (OCGN), Plug Power (PLUG) and QuoteMedia (QMCI).

What is US Nuclear's stock symbol?

US Nuclear trades on the OTCMKTS under the ticker symbol "UCLE."

How do I buy shares of US Nuclear?

Shares of UCLE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is US Nuclear's stock price today?

One share of UCLE stock can currently be purchased for approximately $0.26.

How many employees does US Nuclear have?

US Nuclear employs 6 workers across the globe.

What is US Nuclear's official website?

The official website for US Nuclear is new.usnuclearcorp.com.

Where are US Nuclear's headquarters?

How can I contact US Nuclear?

US Nuclear's mailing address is 7051 Eton Ave, CANOGA PARK, CA 91303-2112, United States. The company can be reached via phone at (818) 883-7043.


This page was last updated on 12/7/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.